All Type of News
Dongwha to sell $500 Mil. worth of technologies to P&G.
Dongwha announced at the Press Center on July 2 that the company agreed to sell the technology of DW1350, an innovative new drug for the treatment of osteoporosis, at about U$511 million to P&G, a gigantic American co...
KFDA set to extend validation waiver for GMP
The Korea Food and Drug Administration is expected to support a plan to recognize the conventional drugs whose GMP (Good Manufacturing Practice) validation was fulfilled based on the in-house regulations of pharmaceu...
Pharmacists call for more attention to diversification of drug supply
The Korea Pharmaceutical Association has recently called on 11 multinational drug manufacturers to pay more attention to drug supply, stressing their possible role in extending their direct transactions with wholesale...
Patent linkage system to be postponed by 18 months
Korea and the Unites States signed their landmark free trade agreement on June 29, after both sides agreed on FTA amendments.
The changes include stronger labor and environmental standards as requested by the U.S. ...
Hanmi to launch a modified new anti-obesity drug.Hanmi is now ready to launch a modified new anti-obesity drug called Slimmer capsule containing sibutramine mesilate after the KFDA approval at the early of July.
Slimmer w...
|
Dong-A's Stillen showing robust sales in first quarter
Dong-A Pharmaceutical' said it anti-ulcerant drug Stillen recorded brisk sales of 14.0 billion won in the first quarter of this year, thanks to superior efficacy and intensive marketing in the domestic market where ho...
7 of 10 diabetic patients evading insulin therapy.
A survey conducted by a diabetic portal site "www.dang119.com" from April 1 to 20 compiled the data from the total 506 patients and found that 7 of 10 diabetic patients were not complying to the physician's recommenda...
Wholesalers betting on fiver-day workweek
More and more wholesalers are preparing to opt for the five-day workweek system as part of their efforts to recruit young people, amid Korean society's growing interest in the value of leisure time and raising the qua...
[NEWS FOCUS] Rocky road ahead
Rough sail is expected between domestic wholesalers and Zuellig Pharma Korea (ZPK) till 17 multinational drug manufacturers will withdraw their exclusive rights offered
to ZPK.
Domestic drug wholesalers and (ZPK)...
MSD vaccine business went far ahead to GSK in Korea.
A sharp business competition between GSK and MSD seems to surface on the market
with the cervical cancer and rotavirus vaccines.
MSD Korea snatched the market initiative with Rotateq, a rotavirus vaccine, in more...
